EUVIMEDEUVIMED entdecken
Crossref

Near-Infrared II Photoactivatable Prodrug Enables Tumor-Specific Stimulator of Interferon Genes Activation for Synergistic Photodynamic Immunotherapy

Chunlin Ren, Jie Yang, Yu Tian, Yanju Liu, Taotao Ding, Qiusi Luo, Yuqin Liao, Hongmei Xia iD, Xiaodong Zeng iD, Xuechuan Hong iD, Yuling Xiao

Journal of Medicinal Chemistry · 26.03.2026 · 69 (6) · 7187-7199

DOI: 10.1021/acs.jmedchem.5c03498 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 12.03.2026. Verfasst von Chunlin Ren und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Zhongnan Hospital of Wuhan University, School of Pharmaceutical Sciences, Wuhan University, Wuhan 430071, China. Hauptthemen laut MEDLINE: Prodrugs, Photochemotherapy, Photosensitizing Agents, Immunotherapy. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: Taishan Scholar Project of Shandong Province, Bill and Melinda Gates Foundation, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The stimulator of interferon genes (STING) pathway is a promising target for cancer immunotherapy, but systemic activation often induces severe toxicity and cytokine storms. To overcome this challenge, we developed a near-infrared II (NIR-II) photoactivatable prodrug, HTAM, for targeted STING activation in the "cold" tumor microenvironment of triple-negative breast cancer. HTAM integrates a mitochondria-targeted photosensitizer (HD) with the STING agonist MSA-2 via a reactive oxygen species (ROS)-cleavable thioacetal-diol linker, enabling efficient tumor targeting and accumulation. Upon 808 nm laser irradiation, HD-generated ROS trigger linker cleavage and spatiotemporally controlled MSA-2 release at the tumor site, thereby activating the STING pathway while minimizing off-target effects. Concurrently, the photodynamic therapy induces DNA damage and immunogenic cell death, amplifying STING signaling and type I interferon production. This synergistic strategy promotes dendritic cell maturation, enhances cytotoxic T lymphocyte infiltration, and effectively reprograms the immunosuppressive microenvironment in the aggressive 4T1 model.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProdrugsPhotochemotherapyPhotosensitizing AgentsImmunotherapyMembrane ProteinsAntineoplastic AgentsAnimalsFemaleHumansMicecGAS-STING Signaling PathwayInfrared RaysReactive Oxygen SpeciesSTING ProteinTumor MicroenvironmentCell Line, Tumor

Substanzen

ProdrugsPhotosensitizing AgentsReactive Oxygen SpeciesSTING ProteinMembrane ProteinsAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Radiology, Zhongnan Hospital of Wuhan University, School of Pharmaceutical Sciences, Wuhan University, Wuhan 430071, China.
  • School of Pharmaceutical Sciences, Key Laboratory of Smart Drug Delivery, Ministry of Education, Fudan University, Shanghai 201203, China.
  • National Key Laboratory of Advanced Drug Formulations for Overcoming Delivery Barriers, Fudan University, Shanghai 201203, China.
  • Department of Pharmacy, Anhui University of Chinese Medicine, Hefei 230012, China.
  • State Key Laboratory of Drug Research & Center of Pharmaceutics, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
  • Shandong Laboratory of Yantai Drug Discovery, Bohai Rim Advanced Research Institute for Drug Discovery, Yantai 264117, China.

ORCID-Profile: Hongmei Xia, Xiaodong Zeng, Xuechuan Hong

Förderung

  • Taishan Scholar Project of Shandong Province
  • Bill and Melinda Gates Foundation
  • National Natural Science Foundation of China
  • Natural Science Foundation of Shandong Province
  • Science and Technology Plan Projects of Tibet Autonomous Region
  • Shandong Province
  • Guangdong Basic and Applied Basic Research Foundation
  • Shenzhen Science and Technology Research Grant

Zitieren

APA

Ren, C., Yang, J., Tian, Y., Liu, Y., Ding, T., Luo, Q., Liao, Y., Xia, H., Zeng, X., Hong, X., & Xiao, Y. (2026). Near-Infrared II Photoactivatable Prodrug Enables Tumor-Specific Stimulator of Interferon Genes Activation for Synergistic Photodynamic Immunotherapy. Journal of Medicinal Chemistry, 69(6), 7187-7199. https://doi.org/10.1021/acs.jmedchem.5c03498

Vancouver

Ren C, Yang J, Tian Y, Liu Y, Ding T, Luo Q, et al. Near-Infrared II Photoactivatable Prodrug Enables Tumor-Specific Stimulator of Interferon Genes Activation for Synergistic Photodynamic Immunotherapy. Journal of Medicinal Chemistry. 2026;69(6):7187-7199. doi:10.1021/acs.jmedchem.5c03498

BibTeX
@article{Ren2026,
  author = {Ren, Chunlin and Yang, Jie and Tian, Yu and Liu, Yanju and Ding, Taotao and Luo, Qiusi and Liao, Yuqin and Xia, Hongmei and Zeng, Xiaodong and Hong, Xuechuan and Xiao, Yuling},
  title = {Near-Infrared II Photoactivatable Prodrug Enables Tumor-Specific Stimulator of Interferon Genes Activation for Synergistic Photodynamic Immunotherapy},
  journal = {Journal of Medicinal Chemistry},
  year = {2026},
  volume = {69},
  number = {6},
  pages = {7187--7199},
  doi = {10.1021/acs.jmedchem.5c03498}
}
Kostenlos starten →